Ms. Hillary Chan


Affiliations: Clinical Transplant Systems, Trillium Gift of Life Network

Project analyst , Project analyst

Research Interests:

Disruptive innovation, knowledge translation, commercialization, implementation, management

Brief Bio:

Hillary recently earned her undergraduate degree from U of T with a diverse background (major: Health & Disease; Minor: Contemporary Asian Studies; Minor: Writing & Rhetoric). She carries a passion to help the senior population, and a particular interest in improving the way healthcare is delivered to patients. In the past, Hillary has managed and executed various research thesis projects (lab and clinical) with Sunnybrook Hospital, St. Michael's hospital, and Shandong University School of Medicine (in coordination with Qilu Hospital). She has also upstarted an initiative for helping seniors (The Young Senior) and other humanitarian support endeavours. Some of these endeavours include working with children with HIV/AIDs in Jamaica and supporting medical teams in delivering healthcare in rural Guatemala. This summer, she was invited back to Shandong University to teach nursing students English and advise on how a university can fully submerge into translational research. Keen on ensuring products, policies or laws are carried all the way through to the patient in an accessible and transparent manner, she has chosen to focus on the commercialization and implementation stages of translational research. She cannot wait see how her TRP journey will unfold.

Capstone Project:

Improved efficacy of research and education in the laboratory

Latner Thoracic Surgery Research Laboratories (LL) is one of the most successful research programs worldwide in lung cancer and lung transplant research. LL publishes one peer-reviewed publication every two weeks. On the translational front, this program has developed ground-breaking clinical applications of which Ex-vivo Lung Perfusion (EVLP) is a good example. EVLP is a revolutionary technique to assess and treat donor lungs and has been translated into clinical use in Canada and is now pending regulatory approval for use in the U.S.

Twitter Handle:



Site URL: